# MicroByre

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/microbyre

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.microbyre.com
- Total disclosed funding: $14M
- Latest round: Series A (Jan 7, 2022)
- Investors on record: 6

## About

MicroByre, Inc. develops innovative microbial management solutions to enhance bioprocessing efficiency. Their technologies are crucial for various industries, including pharmaceuticals and agriculture, focusing on optimized microbial cultivation and operational sustainability.Founded in 2017 in Berkeley, US, MicroByre, Inc. specializes in microbial management technologies. The company has successfully completed four deals, with their most recent funding round being a Series A in January 2022, where they raised USD 10.70 mn, led by Lowercarbon Capital. The company is valued at USD 52.17 mn post-money. CEO Sarah Richardson oversees operations, continuing the vision established by founder Maggie Brown.Microbyre specializes in innovative solutions designed to optimize microbial management and enhance bioprocessing efficiency. Their core product offerings include advanced microbial cultivation systems and bioreactor technologies that support a range of applications, including pharmaceuticals, agriculture, and environmental remediation. These systems are engineered to streamline the growth and maintenance of microbial cultures, facilitating higher yields and improved product consistency. The company serves a diverse client base, including biotechnology firms, research institutions, and agricultural enterprises, primarily in North America, Europe, and select markets in Asia. By addressing critical challenges in microbial scalability and performance, Microbyre's products have gained traction among end-users seeking reliable and efficient microbial solutions.Microbyre generates revenue through a structured combination of direct sales and subscription services associated with their advanced microbial systems. The company’s flagship products are typically sold on a unit basis, with clients making purchases for specific applications, while ongoing support and maintenance may be included in subscription plans. The transaction structure often involves partnerships with biotechnology firms that integrate Microbyre’s systems into their own processes, enhancing their product offerings. Pricing is determined based on the complexity and specifications of the systems, allowing for tailored solutions that meet the unique needs of each client. By fostering long-term relationships with customers and providing exceptional value through their technology, Microbyre successfully maintains a robust revenue stream.In January 2022, MicroByre, Inc. raised USD 10.70 mn in Series A funding led by Lowercarbon Capital, with participation from Impact Science Ventures, Safar Partners, and SystemiQ. This funding will be utilized to develop new microbial technologies aimed at launching innovative products designed for improved bioprocessing applications within pharmaceuticals and agriculture. The company plans to target expansion into European and Asian markets by the end of 2023, focusing on strategic partnerships to enhance market penetration. The funds will also support the scaling of their existing systems to meet the growing demand for efficient microbial management solutions.

## Funding rounds

- Series A, Jan 7, 2022, $11M — SystemiQ, Safar Partners, Lowercarbon Capital, Impact Science Ventures
- Seed, Apr 26, 2019, $3M — Planetary Technologies, PRIME Impact Fund

## Investors

- Planetary Technologies (https://capitalatlas.ai/funds/planetary-technologies) — Seed
- PRIME Impact Fund (https://capitalatlas.ai/funds/prime-impact-fund) — Seed
- SystemiQ (https://capitalatlas.ai/funds/systemiq) — Series A
- Safar Partners (https://capitalatlas.ai/funds/safar-partners) — Series A
- Lowercarbon Capital (https://capitalatlas.ai/funds/lowercarbon-capital) — Series A
- Impact Science Ventures (https://capitalatlas.ai/funds/impact-science-ventures) — Series A